Corrigendum to “double sword role of EZH2 in leukemia” [Biomed. Pharmacother. 98 (2018) 626–635]
- Sahar Safaei
- , Behzad Baradaran
- , Majid Farshdousti Hagh
- , Mohammad Reza Alivand
- , Mehdi Talebi
- , Tohid Gharibi
- , Saeed Solali
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.